By Erin Greene on 01/08/13 at 4:47 pm
In accordance with Article 14.5 of the World Anti-Doping Code, WADA has traditionally published two annual sets of testing figures: the first set reported by the WADA accredited laboratories on analyses performed, and the second by Anti-Doping Organizations (ADOs) on their doping control activities.
In 2012, for the very first time, figures have been compiled entirely from the Anti-Doping Administration and Management System (ADAMS), the system through which all WADA accredited laboratories report their positive and negative findings.
This advanced method of data collation means that there is no longer a requirement for the publication of a second set of testing figures - the separate ADO Testing Figures Report - later in the year.
This new report, using ADAMS, combines the laboratory and ADO testing data in urine, blood and Athlete Biological Passport samples, and has allowed for the most transparent reflection of the global state of anti-doping testing to-date.
It is important to note that the number of Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs) reported by laboratories may not correspond with the number of Anti-Doping Rule Violations (ADRVs) reported by ADOs. This is because all results are subject to a results management process conducted by ADOs, which includes matching results with Therapeutic Use Exemptions (TUEs) and longitudinal studies.
In addition, one single result in the report does not necessarily correspond to one athlete. Results could correspond to multiple findings on the same athlete or measurements performed on the same athlete, such as in the case of longitudinal studies in testosterone.
For a more complete overview of the Testing Figures, please consult the comprehensive Questions and Answers document.
Click here for the 2012 Anti-Doping Testing Figures Report.